SGLT1 was significantly overexpressed in HER2+ breast cancer tissues as confirmed via IHC staining, which positively correlated with HER2 status, lymph node metastasis, shorter disease-free survival and poor overall survival [100]. The gene discussed is ERBB2; the disease is breast carcinoma.